トップページ > 業 績 > 論文発表 2022年
2022年 論文発表
<英文> 24論文
-
Kuno T, Shimizu T, Kawada C, Kurabayashi A, Zou S, Mogawa H, Tsuda M, Saito M, Inoue K 5-Aminolevulinic acid has a potential to prevent bladder dysfunction in cyclophosphamide-induced haemorrhagic cystitis. Int J Urol 2022 Aug 29;897-904. doi: 10.1111/iju.14928.
-
Kuno T, Shimizu T, Kawada C, Kurabayashi A, Zou S, Mogawa H, Tsuda M, Saito M, Inoue K Pretreatment with 5-aminolevulic acid has a potential to protect cyclophosphamide-induced bladder dysfunction in rats. Continence 2022 June 2(2); 100219. doi: org/10.1016/j.cont.2022.100219
-
Kuno T, Shimizu T, Kawada C, Kurabayashi A, Zou S, Mogawa H, Tsuda M, Saito M, Inoue K 5-Aminolevulic acid prevents cyclophosphamide-induced bladder dysfunction in rats. J Urol. 2022. 207, e117-e118.
-
Kuno T, Tamura K, Fukuhara H, Fukata S, Ashida S, Karashima T, Sawada K, Yasuda M, Watanabe H, Komatsu F, Kuroiwa H, Saito M, Inoue K. Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting. Urol Int. 2022;106(10):1005-1011.
-
Fukata S, Mizutani K, Yamamoto S, Kuno T, Fukuhara H, Ashida S, Karashima T, Inoue K, Sarcopenia and the rate of change of the neutrophil/lymphocyte ratio as predictors of pembrolizumab efficacy in advanced urothelial carcinoma. Anticancer Drugs. 2022 Jun 1;33(5):459-466.
-
Hata Y,Shimizu T,Zou S, Yamamoto, M, Shimizu Y, Ono H, Aratake T, Shimizu S, Higashi Y, Shimizu N, Karashima T, Saito M. Stimulation of brain corticotropin-releasing factor receptor type1 facilitates the rat micturition via brain glutamatergic receptors.Biochem Biophys Res Commun 607:54-59, 2022
-
Zou S, Shimizu T, Kurabayashi A, Yamamoto M, Shimizu S, Higashi Y, Shimizu N, Karashima T, Saito M. Protective effects of hydrogen sulfide pretreatment on cyclophosphamide-induced bladder dysfunction in rats via suppression of bladder afferent nerves. Nitric Oxide 127:54-63, 2022.
-
Hashimoto M, Shimizu N, (corresponding) Fujimoto S, Kuwahara K, Nishimoto M, Adomi S, Banno E, Minami T, Fujita K, Yoshimura K, Hirayama A, Uemura H. The pressure flow study investigation of pathophysiology of post-micturition dribble in male patients. Int Urol Nephrol. 2023 Jan;55(1):69-74.
-
Hashimoto M, Nakayama T, Fujimoto S, Inoguchi S, Nishimoto M, Kikuchi T, Adomi S, Banno E, De Velasco MA, Saito Y, Shimizu N, Mori Y, Minami T, Fujita K, Nozawa M, Nose K, Yoshimura K, Uemura H. Disseminated intravascular coagulation induced by pazopanib following combination therapy of nivolumab plus ipilimumab in a patient with metastatic renal cell carcinoma. Anticancer Drugs. 2022 Jan 1;33(1):e818-e821.
-
Nishimoto M, Fujita K, Yamamoto Y, Hashimoto M, Adomi S, Banno E, Saito Y, Shimizu N, Mori Y, Minami T, Nozawa M, Nose K, Hirayama A, Yoshimura K, Uemura H. Prognostic factors in Japanese men with high-Gleason metastatic castration-resistant prostate cancer. Transl Cancer Res. 2022 Aug;11(8):2681-2687.
-
Wada N, Karnup S, Kadekawa K, Shimizu N, Kwon J, Shimizu T, Gotoh D, Kakizaki H, de Groat WC, Yoshimura N: Current knowledge and novel frontiers in lower urinary tract dysfunction after spinal cord injury: Basic research perspectives. Urol Sci 2022 Sep 33(3) 101-101.
-
Karashima T, Umemoto S, Kishida T, Osaka K, Nakagawa M, Yoshida E, Yoshimura T, Sakaguchi M, Nishimoto H, Tai M, Inoue K, Seiki M, Koshikawa N, Shuin T. Clinical evaluation of urine laminin-γ2 monomer as a potent biomarker for non-muscle invasive bladder cancer. Cancer Med. 2022 Aug 4. doi: 10.1002/cam4.5087.
-
Ito K, Kita Y, Yokomizo A, Miki J, Yoshio Y, Matsumoto H, Segawa T, Karashima T, Nishiyama N, Imai K, Suekane S, Nagasawa S, Higashi S, Nishiyama H, Kitamura H, Kobayashi T. Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study. Cancer Med. 2022 Jul 21. doi: 10.1002/cam4.5057.
-
Shimizu S, Nagao Y, Kurabayashi A, Shimizu T, Higashi Y, Karashima T, Saito M. Effects of losartan on bladder dysfunction due to aging-related severe hypertension in rats. Eur J Pharmacol. 2022 May 5;922:174911. doi: 10.1016/j.ejphar.2022.174911. Epub 2022 Mar 22.
-
Fukuhara H, Yamamoto S, Lai HW, Karashima T, Kurabayashi A, Furihata M, Inoue K. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT. Photodiagnosis Photodyn Ther. 2022 Jun;38:102757. doi: 10.1016/j.pdpdt.2022.102757. Epub 2022 Feb 11.PMID: 35151889
-
Fukuhara H, Szili EJ, Oh JS, Kawada S, Yamamoto S, Kurabayashi A, Furihata M, Tsuda M, Furuta H, Lindsay HD, Short RD, Hatta A and Inoue K. Oxidative Stress Pathways Linked to Apoptosis Induction by Low-Temperature Plasma Jet Activated Media in Bladder Cancer Cells: An In Vitro and In Vivo Study. Plasma, 5, 233–246, 2022. https://doi.org/10.3390/plasma5020018
-
Miyake M, Iida K, Nishimura N, Inoue T, Matsumoto H, Matsuyama H, Fujiwara Y, Komura K, Inamoto T, Azuma H, Yasumoto H, Shiina H, Yonemori M, Enokida H, Nakagawa M, Fukuhara H, Inoue K, Yoshida T, Kinoshita H, Matsuda T, Fujii T, Fujimoto K; Nishinihon Uro-oncology Extensive Collaboration Group. Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy. Eur Urol Open Sci. 2022 May 30;41:95-104.
-
Tohi Y, Kato T, Fukuhara H, Kobayashi K, Ohira S, Ikeda K, Daizumoto K, Katayama S, Shimizu R, Nishimura K, Nagami T, Hayashida Y, Hirama H, Takamoto A, Dainichi T, Sugimoto M; Chu-shikoku Japan Urological Consortium (Inoue k). Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium. Int J Clin Oncol. 2022 Aug;27(8):1348-1355.
-
Maeda H, Kajiwara K, Yoshimatsu R, Yamanishi T, Minamiguchi H, Karashima T, Inoue K, Awai K, Yamagami T. Artificially induced pneumothorax with a Veress needle for cryoablation of renal cell carcinoma. Minim Invasive Ther Allied Technol. 2022 Mar;31(3):483-486.
-
Kajiwara K, Yoshimatsu R, Komoto M, Maeda H, Yamanishi T, Minamiguchi H, Karashima T, Inoue K, Awai K, Yamagami T. Efficacy and safety of CT-guided cryoablation after lipiodol marking and embolization for RCC. Minim Invasive Ther Allied Technol. 2022 Aug;31(6):923-929.
-
Kurabayashi A, Furihata K, Iwashita W, Tanaka C, Fukuhara H, Inoue K, Furihata M, Kakinuma Y. Murine remote ischemic preconditioning upregulates preferentially hepatic glucose transporter-4 via its plasma membrane translocation, leading to accumulating glycogen in the liver. Life Sci. 2022 Feb 1;290:120261. doi: 10.1016/j.lfs.2021.120261. Epub 2021 Dec 27.PMID: 34968468
-
Morisawa S, Jobu K, Ishida T, Kawada K, Fukuda H, Kawanishi Y, Nakayama T, Yamamoto S, Tamura N, Takemura M, Kagimoto N, Ohta T, Masahira N, Fukuhara H, Ogura SI, Ueba T, Inoue K, Miyamura M. Association of 5-aminolevulinic acid with intraoperative hypotension in malignant glioma surgery. Photodiagnosis Photodyn Ther. 2022 Mar;37:102657. doi: 10.1016/j.pdpdt.2021.102657. Epub 2021 Nov 27.PMID: 34848378
-
Kaneko M, Nakayama T, Seki H, Yamamoto S, Inoue K, Hadano S, Watanabe S, Niko Y. Lipophilic nitrile N-oxide for catalyst-free surface modification of nanoemulsions as light-harvesting nanoantennas. Bulletin of the Chemical Society of Japan (BCSJ) 2022, 1760-1768, Vol 95, No12
-
Chadani Y, Kashibayashi T, Yamamoto T, Tsuda A, Fujito R, Akamatsu M, Kamimura N, Takahashi R, Yamagami T, Furuya H, Ueba T, Saito M, Inoue K, Kazui H. Association of right precuneus compression with apathy in idiopathic normal pressure hydrocephalus: a pilot study. Sci Rep. 2022 Nov 28;12(1):20428. doi: 10.1038/s41598-022-23800-x.
<和文> 2論文
-
水谷圭佑, 深田聡, 山本新九郎, 安宅香弥, 太田雄飛, 葺石陽亮, 波越朋也, 久野貴平,大河内寿夫, 福原秀雄,田村賢司, 蘆田真吾, 辛島尚, 井上啓史.当科のPembrolizumab投与症例における末梢血好中球/リンパ球比(NLR)と治療効果の検討.西日泌尿, 84 : 255-262, 2022
-
刑部博人,竹村紗奈,太田雄飛,石黒基純,山本新九郎,福原秀雄,井上啓史,刑部有紀,松本竜季,寺田典生,Over the guidewire法を用いた恒久的バスキュラーアクセス留置術.西日本泌尿器科 (0029-0726)84巻4号 Page398-404(2022.04)